FDA panel considers a first-of-its-kind flu vaccine using mRNA technology ⊖
found
a story from The Guardian ⚠️ › International
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
since
auto-detected in 23 stories
37 days ago
found
a story from The Guardian ⚠️ › International
Moderna seeks FDA approval of its new shot, mFlusvia, as option for 50 and older
US health advisers are debating a new kind of flu vaccine Thursday, the first made with the same mRNA technology that w…
5 months ago
6 months ago
Over the holiday period, the Guardian leader column is looking ahead at the themes of 2026. Today we examine how the White House’s war on vaccines has left the future of a key technology uncertain an…
8 months ago
A study suggesting mRNA vaccines help the body fight malignant cells raises the tantalising prospect of a low-cost, low-risk treatment that could help with all cancers
I’m often asked whether we’re be…
10 months ago
The CDC – the federal agency in charge of protecting the health of Americans – is in shambles. And that is all thanks to one man
Things seem to be going well at the CDC, the federal agency charged wit…
11 months ago
The decision by the US health and human services secretary to remove mRNA research funding is ill-informed and dangerous
Science is not black and white. It’s more complicated and more exciting. It’s a…
The avian flu virus is now just one mutation away from easier transmission among humans. Donald Trump’s health chief is a grave risk to world health
Prof Devi Sridhar is chair of global public health …